PolyPid Announces Successful Commercial Good Manufacturing
Successful Audit of the Company’s State-of-the-Art Manufacturing Facility Represents a Key Milestone Toward Plan to Commercialize D-PLEX₁₀₀ Globally...
Stay updated with breaking news from Polypid Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Successful Audit of the Company’s State-of-the-Art Manufacturing Facility Represents a Key Milestone Toward Plan to Commercialize D-PLEX₁₀₀ Globally...
19.09.2023 - Company has Successfully Completed the Production of Three Process Validation Batches at Commercial Scale Completes a Substantial Requirement Toward the Planned Submission of D-PLEX100 NDA and MAA Regulatory Filings PETACH TIKVA, Israel, Sept. ... Seite 1
PolyPid Ltd. (NASDAQ:PYPD – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 13,300 shares, a decrease of 81.3% from the August 15th total of 71,100 shares. Based on an average daily trading volume, of 66,000 shares, […]
PolyPid (NASDAQ:PYPD – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares PolyPid and Merit Medical […]